SCHEMBL7080304

SCHEMBL7080304

Cc1ccccc1C1(CCCN)C2CC3CC(C2)CC1C3

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 7/20 0.38
SIGMAR1 Q99720 3/20 0.35
GRIN2D O15399 3/20 0.35
GRIN3B O60391 3/20 0.35
GRIN1 Q05586 3/20 0.35
GRIN2A Q12879 3/20 0.35
GRIN2B Q13224 3/20 0.35
GRIN2C Q14957 3/20 0.35
GRIN3A Q8TCU5 3/20 0.35
P2RX7 Q99572 2/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
TAAR1 Q96RJ0 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7079630 0.99 HSD11B1 (0.38) HSD11B1SIGMAR1GRIN2DGRIN3BGRIN1
SCHEMBL7082807 0.96 HSD11B1 (0.38) HSD11B1SIGMAR1GRIN2DGRIN3BGRIN1
Hydrochloric Acid SCHEMBL7079481 0.94 HSD11B1 (0.37) HSD11B1SIGMAR1GRIN2DGRIN3BGRIN1
SCHEMBL6686003 0.91 HSD11B1 (0.40) HSD11B1SIGMAR1GRIN2DGRIN3BGRIN1
Hydrochloric Acid SCHEMBL6685252 0.90 HSD11B1 (0.39) HSD11B1SIGMAR1GRIN2DGRIN3BGRIN1
SCHEMBL7079499 0.84 HSD11B1 (0.39) HSD11B1GRIN2DGRIN3BGRIN1GRIN2A
Hydrochloric Acid SCHEMBL6899621 0.83 HSD11B1 (0.40) HSD11B1SIGMAR1GRIN2DGRIN3BGRIN1
Hydrochloric Acid SCHEMBL7135312 0.83 HSD11B1 (0.38) HSD11B1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7079043 0.82 HSD11B1 (0.37) HSD11B1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL7079468 0.82 HTR2A (0.37) HSD11B1SIGMAR1P2RX7HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003064372-A1 2-ADAMANTYLALKYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION VERNALIS RESEARCH LIMITED (GB) 2003-08-07 WO claimed
WO-2003064372-A1 2-ADAMANTYLALKYLAMINES AND THEIR USE IN THE TREATMENT OF CONDITIONS GENERALLY ASSOCIATED WITH ABNORMALITIES IN GLUTAMATERGIC TRANSMISSION VERNALIS RESEARCH LIMITED (GB) 2003-08-07 WO disclosed